Tofersen Demonstrates Clinical Benefit in Adults With SOD1-ALS: Final VALOR and OLE Results
Final results from the VALOR trial and its open-label extension demonstrated the clinical benefit of tofersen in adults with SOD1-ALS, providing a clear rationale for initiating therapy in this population.…